Reconnect Labs AG

Swiss Precision Psychiatry

Reconnect Labs is a Swiss, clinical stage biotech company designing precision therapeutics that restore mental balance — bridging science and human connection.
We’re not just developing drugs—we’re redefining mental health care.

Precision drug targets: Activating key areas of the brain, like the "blue dot" for sleep.
Proven compounds: Derisked molecules reformulated for safety and efficacy.
Restorative: Modulating mental states with precision, not sedation.
Whole-system approach: Addressing bio, psycho, and social dimensions of mental health.

How we’re different:
OTHERS target single biological factors. WE treat the whole system.
OTHERS dull negative symptoms. WE amplify positive traits.
OTHERS suppress, sedate, and manage. WE restore, uplift, and strengthen.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No milestones

No Jobs

Documents

UZH Spin-off

Website

Reconnect Labs AG

Swiss Precision Psychiatry

Headquarter:
Winterthur

Foundation Date:
March 2021

Technology:

  • Biotech

Sectors:

  • Neurology
  • Small molecule drugs